Cellular platforms for HTS: three case studies

PA Johnston, PA Johnston - Drug discovery today, 2002 - Elsevier
The field of cell-based screening is expanding rapidly as innovations in target selection and
instrumentation increase the number of targets that can be efficiently screened in cellular …

Scintillation proximity assays in high-throughput screening

JF Glickman, A Schmid, S Ferrand - Assay and drug development …, 2008 - liebertpub.com
Scintillation proximity assays (SPAs) have become a powerful tool for high-throughput
screening (HTS) because they can measure the activity and binding of very diverse classes …

Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription

LM Schang, J Phillips, PA Schaffer - Journal of virology, 1998 - Am Soc Microbiol
Several observations indicate that late-G1/S-phase-specific cellular functions may be
required for herpes simplex virus (HSV) replication:(i) certain mutant HSV strains are …

Biochemical and cellular effects of c-Src kinase-selective pyrido [2, 3-d] pyrimidine tyrosine kinase inhibitors

AJ Kraker, BG Hartl, AM Amar, MR Barvian… - Biochemical …, 2000 - Elsevier
Increased expression or activity of c-Src tyrosine kinase has been associated with the
transformed phenotype in tumor cells and with progression of neoplastic disease. A number …

Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay

AA Jensen, H Bräuner-Osborne - Biochemical pharmacology, 2004 - Elsevier
We have expressed the human excitatory amino acid transporters EAAT1, EAAT2 and
EAAT3 stably in HEK293 cells and characterized the transporters pharmacologically in a …

Ex Vivo Activity of Cardiac Glycosides in Acute Leukaemia

H Hallböök, J Felth, A Eriksson, M Fryknäs, L Bohlin… - PloS one, 2011 - journals.plos.org
Background Despite years of interest in the anti-cancerous effects of cardiac glycosides
(CGs), and numerous studies in vitro and in animals, it has not yet been possible to utilize …

Temporal effects of the novel antitumour pyridyl cyanoguanidine (CHS 828) on human lymphoma cells

P Martinsson, G Liminga, S Dhar, M De la Torre… - European Journal of …, 2001 - Elsevier
CHS 828, a novel pyridyl cyanoguanidine, has shown potent antitumour activity both in vitro
and in vivo and is currently undergoing phase I evaluation in humans in collaboration with …

Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-pL-fluorophenylalanine ethyl ester) and P2 (L-prolyl-mL-sarcolysyl-pL-fluorophenylalanine ethyl …

J Gullbo, S Dhar, K Luthman, H Ehrsson… - Anti-cancer …, 2003 - journals.lww.com
Peptichemio, a mixture of six short oligopeptides all comprising the alkylating amino acid mL-
sarcolysin, has shown clinical activity in several malignancies. Previous studies have …

Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms

K Hellwig, FJ Stein, H Przuntek, T Müller - BMC neurology, 2004 - Springer
Background There are controversial results on the efficacy of the abandoned, intrathecal
predominant methylprednisolone application in multiple sclerosis (MS) in contrast to the …

Early stimulation of acidification rate by novel cytotoxic pyridyl cyanoguanidines in human tumor cells: comparison with m-iodobenzylguanidine

S Ekelund, G Liminga, F Björkling, E Ottosen… - Biochemical …, 2000 - Elsevier
CHS 828, a newly recognized pyridyl cyanoguanidine, has shown promising antitumor
activity both in vitro and in vivo and is presently in early phase I clinical trial in collaboration …